Summary of Purpose
Currently, there is no reliable biomarker for stroke, meaning that treatment is often delayed and patients are often left with a disability. Stroke is one of the largest causes of mortality (death) and morbidity (disease) in the UK and affects around 120 and 15 people per 100,000 population. This has huge economic implications, with around £9 billion a year being spent on stroke in the UK alone, and health and...Read More →
The following dates are available for this trial. Trial information last updated on 16 February 2018.
|1 Mar 2018||16 Feb 2018||1 Mar 2019||1 Mar 2019||1 Feb 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|